PFMU
AUPH icon

Privium Fund Management (UK)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Privium Fund Management (UK)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-67,853
Closed -$593K – 93
2023
Q4 		$593K Buy
+67,853
New +$559K 0.4% 49
2022
Q3 		– Sell
-29,000
Closed -$291K – 60
2022
Q2 		$291K Buy
29,000
+3,791
+15% +$42.4K 0.33% 67
2022
Q1 		$312K Buy
25,209
+5,209
+26% +$80.5K 0.18% 86
2021
Q4 		$460K Hold
20,000
– – 0.36% 34
2021
Q3 		$443K Buy
+20,000
New +$317K 0.48% 42

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Privium Fund Management (UK)'s AUPH Position: Q1 2024 in Review

Privium Fund Management (UK) sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 67,853 shares — an estimated $593K sold.

Privium Fund Management (UK) first reported a position in AUPH in Q3 2021 and held it in 5 quarters. The position peaked at $593K in Q4 2023. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Privium Fund Management (UK) reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Privium Fund Management (UK) sold 67,853 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $593K.
  • Privium Fund Management (UK) first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • Privium Fund Management (UK)'s Aurinia Pharmaceuticals position peaked at $593K in Q4 2023.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Privium Fund Management (UK)'s 13F filing for Q1 2024, filed 29 Apr 2024.